Design, synthesis, in vitro anti-α-glucosidase evaluations, and computational studies of new phthalimide-phenoxy-1,2,3-triazole-N-phenyl (or benzyl) acetamides as potential anti-diabetic agents.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 06 2023
Historique:
received: 29 11 2022
accepted: 12 06 2023
medline: 22 6 2023
pubmed: 21 6 2023
entrez: 20 6 2023
Statut: epublish

Résumé

An important target in the treatment of type 2 diabetes is α-glucosidase. Inhibition of this enzyme led to delay in glucose absorption and decrease in postprandial hyperglycemia. A new series of phthalimide-phenoxy-1,2,3-triazole-N-phenyl (or benzyl) acetamides 11a-n were designed based on the reported potent α-glucosidase inhibitors. These compounds were synthesized and screened for their in vitro inhibitory activity against the latter enzyme. The majority of the evaluated compounds displayed high inhibition effects (IC

Identifiants

pubmed: 37340010
doi: 10.1038/s41598-023-36890-y
pii: 10.1038/s41598-023-36890-y
pmc: PMC10282079
doi:

Substances chimiques

alpha-Glucosidases EC 3.2.1.20
Acetamides 0
Triazoles 0
Hypoglycemic Agents 0
Glycoside Hydrolase Inhibitors 0
Phthalimides 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10030

Informations de copyright

© 2023. The Author(s).

Références

Eur J Med Chem. 2015 Nov 13;105:156-70
pubmed: 26491979
Bioorg Med Chem. 2010 Aug 15;18(16):5903-14
pubmed: 20667739
Nucleic Acids Res. 2009 Jan;37(Database issue):D387-92
pubmed: 18931379
Chem Biol Drug Des. 2016 Mar;87(3):361-73
pubmed: 26362113
J Cell Physiol. 2017 Dec;232(12):3631-3640
pubmed: 28145580
Bioorg Chem. 2020 Jan;95:103482
pubmed: 31838286
Expert Opin Pharmacother. 2019 Dec;20(18):2229-2235
pubmed: 31593486
Plants (Basel). 2022 Oct 14;11(20):
pubmed: 36297746
Food Sci Nutr. 2020 Nov 04;8(12):6320-6337
pubmed: 33312519
Bioorg Med Chem. 2008 Apr 15;16(8):4272-85
pubmed: 18343126
J Med Chem. 2020 Apr 23;63(8):4205-4214
pubmed: 32227946
Biochemistry (Mosc). 2011 Jun;76(6):622-35
pubmed: 21639842
Antiviral Res. 2007 Oct;76(1):30-7
pubmed: 17548120
Eur J Med Chem. 2019 Aug 15;176:343-377
pubmed: 31112894
J Comput Chem. 2011 Aug;32(11):2359-68
pubmed: 21541964

Auteurs

Mehdi Emadi (M)

Electrical and Computer Engineering Department, Babol Noshirvani University of Technology, Babol, Iran.

Mohammad Halimi (M)

Department of Biology, Babol Branch, Islamic Azad University, Babol, Iran.

Ali Moazzam (A)

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Samanesadat Hosseini (S)

Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Somayeh Mojtabavi (S)

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Mohammad Ali Faramarzi (MA)

Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

Reza Ghadimi (R)

Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.

Ali Akbar Moghadamnia (AA)

Department of Pharmacology and Toxicology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.

Ensieh Nasli-Esfahani (E)

Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Maryam Mohammadi-Khanaposhtani (M)

Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran. maryammoha@gmail.com.

Mohammad Mahdavi (M)

Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. momahdavi@tums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH